Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group

PURPOSE: The treatment landscape in metastatic renal cell carcinoma (mRCC) has evolved dramatically in recent years. Within the German guideline committee for RCC we evaluated current medical treatments and gave recommendations. METHODS: A systematic review of published evidence for medical treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Grünwald, V., Bergmann, L., Brehmer, B., Eberhardt, B., Kastrati, Karin, Gauler, T., Gehbauer, G., Gschwend, J., Johannsen, M., Klotz, T., Protzel, C., Schenck, M., Staehler, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512709/
https://www.ncbi.nlm.nih.gov/pubmed/35562599
http://dx.doi.org/10.1007/s00345-022-04015-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512709/
https://www.ncbi.nlm.nih.gov/pubmed/35562599
http://dx.doi.org/10.1007/s00345-022-04015-1

Ejemplares similares